Showing results (231-240 of 244) with videos related to
Sort By:
Pageof 25
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 26, 2024
Coconut Water Induces Clinical Remission in Mild to Moderate Ulcerative Colitis: Double-blind Placebo-controlled TrialSaurabh Kedia, Shubi Virmani, Aditya Bajaj, et al.BMC Rheumatology|February 29, 2024
Association between Impella device support and elevated rates of gout flares: a retrospective propensity-matched studyJorge Sinclair De Frías, Shahin Isha, Lorenzo Olivero, et al.Journal of Medicinal Chemistry|January 11, 2013
Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitorsAnna Kohlmann, Stephan G Zech, Feng Li, et al.Journal of Medicinal Chemistry|July 4, 2009
9-(Arenethenyl)purines as dual Src/Abl kinase inhibitors targeting the inactive conformation: design, synthesis, and biological evaluationWei-Sheng Huang, Xiaotian Zhu, Yihan Wang, et al.Translational Lung Cancer Research|August 13, 2025
Prognostic significance of micropapillary pattern and risk factors in patients with resected stage I lung adenocarcinoma and possible benefit of adjuvant therapy: a real-world multicenter studyJianjie Li, Yujia Chi, Bo Jia, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 4, 2026
Clinical Outcomes of Pre-Transplant Cardiac Prehabilitation in the ICU on Impella 5.5Anek Jena, Aayushi Pareek, Said Bateh, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 21, 2025
Impella 5.5 as Heart Transplant Bridge Facilitated Rehabilitation and Improves Post-Transplant Outcomes: Retrospective Cohort StudySadhana Jonna, Gustavo Olaizola, Lekhya Raavi, et al.Cancer Cell|November 3, 2009
AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistanceThomas O'Hare, William C Shakespeare, Xiaotian Zhu, et al.Bioorganic & Medicinal Chemistry Letters|May 13, 2011
Discovery of 5-(arenethynyl) hetero-monocyclic derivatives as potent inhibitors of BCR-ABL including the T315I gatekeeper mutantMathew Thomas, Wei-Sheng Huang, David Wen, et al.JAMA Internal Medicine|April 20, 2026
Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease: A Randomized Clinical TrialHimanshu Narang, Daizee Talukdar, Bipul Kumar, et al.Pageof 25